Key facts
- This page summarizes Stephen Feider's Form 4 filing for Beta Bionics, Inc. (BBNX).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 03 Feb 2025, 20:30.
Stephen Feider - 31 Jan 2025 Form 4 Insider Report for Beta Bionics, Inc. (BBNX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- BBNX
- Reported as of
- 31 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Feb 2025, 20:30:08 UTC
- Prior SEC filing
- 29 Jan 2025
- Next SEC filing
- 03 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen Feider
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stephen Feider filed Form 4 for Beta Bionics, Inc. (BBNX) on 03 Feb 2025.
Change
- Previous filing in this sequence was filed on 29 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BBNX
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +166,542
- Change %
- Price
- $0.000000
- Shares after
- 166,542
- Date
- 31 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 166,542
- Exercise price
- $7.51
- Footnotes
- F1, F2
BBNX
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +109,695
- Change %
- Price
- $0.000000
- Shares after
- 109,695
- Date
- 31 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 109,695
- Exercise price
- $5.10
- Footnotes
- F2, F3
BBNX
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +186,203
- Change %
- Price
- $0.000000
- Shares after
- 186,203
- Date
- 31 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 186,203
- Exercise price
- $17.00
- Footnotes
- F2, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
One-fourth of the shares subject to this option shall vest one year after August 1, 2022, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
Footnote F2
Immediately prior to the closing of the initial public offering, each share of Class B Common Stock subject to this option was converted into an equal number of shares of Common Stock.
Footnote F3
The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Footnote F4
Vesting is monthly over a 48-month period starting January 29, 2025 in equal monthly amounts.